Lilly will acquire Curevo in a deal worth up to $1.5 billion in cash, including upfront and milestone-based payments.
NEJM study shows strong protection across strains
C. P. Radhakrishnan urged graduates to uphold ethical standards and maintain a commitment to patient care
Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits
The perinatology CME at Navi Mumbai brought together more than 100 obstetricians, pediatricians, and neonatologists
Nature Medicine study delivers strongest real-world evidence yet for India’s indigenous rotavirus vaccine under UIP
The data will be presented at the 2026 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress in Munich, April 17-21
Previously, Arexvy was authorized for adults 60 and older, and for those 50–59 with heightened risk
The decision marks a pivotal moment for the Massachusetts-based biotech giant
The initiative, funded entirely under the company’s CSR programme, is expected to reach over a million lives
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
